ve818
Cell therapyexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2025 (NCT06817031)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- microbiotaSupplementation
microbiota supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07207434 | Phase 2 | Aug 30, 2025 | Aga Khan University, Bill and Melinda Gates Foundation, Institut Pasteur, International Center for Diarrheal Disease Research, University of Zambia |
| NCT07134790 | Phase 2 | Jul 30, 2025 | Bill and Melinda Gates Foundation, Ghent University |
| NCT06817031 | Phase 2 | Apr 30, 2025 | Bill and Melinda Gates Foundation, International Center for Diarrheal Disease Research |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 3 | 0 | 1 | 2025 |
| International Center for Diarrheal Disease Research | Academic/Hospital | 2 | 1 | 1 | 2025 |
| Aga Khan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Ghent University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Institut Pasteur | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Zambia | Academic/Hospital | 1 | 0 | 1 | 2025 |
6 organizations
Page 1 / 1